Purchases and Sales Made in Q2 2022 in Cyma Bay Therapeutics, Inc. (CBAY)
This table provides information about the institutional ownership of Cyma Bay Therapeutics, Inc. (CBAY) during Q2 2022. The information is specifically focused on institutions that hold shares of CymaBay Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 15, 2022
Q2 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-191K- 79.68% |
$328K - $646K
|
48.6K
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-194KClosed |
$333K - $656K
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Bank Of New York Mellon Corp
New York, NY |
SELL
|
- |
-248K- 89.47% |
$426K - $839K
|
29.1K
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-285K- 7.43% |
$491K - $967K
|
3.56M
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-288KClosed |
$495K - $976K
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-309K- 54.79% |
$532K - $1.05M
|
255K
$0
|
|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-376K- 59.56% |
$646K - $1.27M
|
255K
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-593K- 81.01% |
$1.02M - $2.01M
|
139K
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-604K- 45.89% |
$1.04M - $2.05M
|
713K
$0
|
|
|
Aug 15, 2022
Q2 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-996K- 73.34% |
$1.71M - $3.38M
|
362K
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-1M- 66.67% |
$1.72M - $3.39M
|
500K
$0
|
|
|
Aug 11, 2022
Q2 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.3M- 99.74% |
$2.24M - $4.41M
|
3.34K
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-3.51M- 64.27% |
$6.04M - $11.9M
|
1.95M
$0
|